Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IHE vs. FHLC: which is better?

Bottom line

IHE vs FHLC: the short answer

IHE (iShares U.S. Pharmaceuticals ETF) and FHLC (Fidelity MSCI Health Care Index ETF) share a meaningful slice of their top holdings — about 41% by weight.

But FHLC is far broader, holding 337 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.

FHLC is cheaper at 0.084% vs 0.37% — a difference of $29 a year per $10,000 invested.

Over five years, IHE returned +9.1% a year vs +7.2% for FHLC (reporting dates differ).

Updated Nov 19, 2026

IHE vs FHLC side by side

IHEFHLC
TypeETFETF
Fund familyiSharesFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.37%0.084%
Annual cost per $10k$37$8.4
10-yr cost on $10k (prospectus)$468$108
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+31.7%+2.6%
5-yr return (annualized)+9.1%+7.2%
10-yr return (annualized)+6.2%+8.8%
Best quarter+17.6%+16.4%
Worst quarter−16.0%−13.1%
Net assets (fund)$1.1B$3.3B
Number of holdings59337
Portfolio turnover29%3%
Returns as ofDec 31, 2025Nov 30, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIHEFHLCDifference
2024+8.1%+2.6%+5.5%
2023+1.0%+2.5%−1.5%
2022−4.8%−5.5%+0.7%
2021+12.8%+20.4%−7.5%
2020+13.8%+18.1%−4.3%
2019+15.5%+21.9%−6.5%
2018−7.7%+5.5%−13.2%
2017+10.7%+23.3%−12.7%
2016−11.7%−3.3%−8.4%
2015+8.8%+7.0%+1.8%

Source: Fund prospectus bar charts

Holdings overlap

5 of IHE's top 25 holdings also appear in FHLC's top 25.

Shared top holdings
HoldingIHEFHLC
Johnson & Johnson22.44%8.93%
Eli Lilly And Company22.25%13.35%
Merck & Co., Inc.4.55%4.66%
Bristol-myers Squibb Company4.37%1.93%
Pfizer Inc.3.96%2.06%

Source: SEC Form N-PORT

IHE top 10

  1. Johnson & Johnson — 22.44%
  2. Eli Lilly And Company — 22.25%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  4. Merck & Co., Inc. — 4.55%
  5. Bristol-myers Squibb Company — 4.37%
  6. Royalty Pharma Plc — 4.34%
  7. Viatris Inc. — 4.22%
  8. Pfizer Inc. — 3.96%
  9. Zoetis Inc. — 3.73%
  10. Jazz Pharmaceuticals Public Limited Company — 3.45%

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

FAQ

What is the difference between IHE and FHLC?
IHE (iShares U.S. Pharmaceuticals ETF) and FHLC (Fidelity MSCI Health Care Index ETF) share a meaningful slice of their top holdings — about 41% by weight. But FHLC is far broader, holding 337 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.
Which is cheaper, IHE or FHLC?
FHLC has the lower expense ratio (0.084%).
Should I own both IHE and FHLC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.